2022
DOI: 10.1021/acscentsci.1c01465
|View full text |Cite
|
Sign up to set email alerts
|

A Facile Platform to Engineer Escherichia coli Tyrosyl-tRNA Synthetase Adds New Chemistries to the Eukaryotic Genetic Code, Including a Phosphotyrosine Mimic

Abstract: The Escherichia coli tyrosyl-tRNA synthetase (EcTyrRS)/tRNA EcTyr pair offers an attractive platform for genetically encoding new noncanonical amino acids (ncAA) in eukaryotes. However, challenges associated with a eukaryotic selection system, which is needed to engineer the platform, have impeded its success in the past. Recently, using a facile E. coli -based selection system, we showed that EcTyrRS could be engineered in a strain where the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
32
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 24 publications
(32 citation statements)
references
References 54 publications
0
32
0
Order By: Relevance
“…To this end, we attempted the expression of full-length Trastuzumab harboring a TAG and a TGA codon at positions 121 of the heavy chain (HC) and 169 of the light chain (LC), respectively, using the EcTrp+EcTyr system (Figure 5A), which showed the highest dual suppression efficiency. The antibody expression cassettes were incorporated into a vector containing a recently developed EcTyrRS (pAAFRS), 39 capable of incorporating an azide-containing amino acid pAAF ( 8 , Figure 1), as well as eight copies of tRNA CUA EcTyr . The pAAF incorporation system was selected due to its high efficiency, as well as the post-translational stability of this azide-ncAA within the reducing cellular environment.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…To this end, we attempted the expression of full-length Trastuzumab harboring a TAG and a TGA codon at positions 121 of the heavy chain (HC) and 169 of the light chain (LC), respectively, using the EcTrp+EcTyr system (Figure 5A), which showed the highest dual suppression efficiency. The antibody expression cassettes were incorporated into a vector containing a recently developed EcTyrRS (pAAFRS), 39 capable of incorporating an azide-containing amino acid pAAF ( 8 , Figure 1), as well as eight copies of tRNA CUA EcTyr . The pAAF incorporation system was selected due to its high efficiency, as well as the post-translational stability of this azide-ncAA within the reducing cellular environment.…”
Section: Resultsmentioning
confidence: 99%
“…The pAAF incorporation system was selected due to its high efficiency, as well as the post-translational stability of this azide-ncAA within the reducing cellular environment. 39 Expi293 suspension cultures were co-transfected with the resulting plasmid along with another plasmid encoding the EcTrpRS/tRNA UCA EcTrp pair. A wild-type antibody, lacking any nonsense codons was also expressed in parallel.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…These machineries were identified from an extensive repository of OTSs available in these organisms that facilitate specific and efficient decoding of multiple orthogonal codons with structurally and functionally diverse ncAAs. (Beránek et al, 2018;Biddle et al, 2022;Cervettini et al, 2020;Gan et al, 2017;Grasso et al, 2022Grasso et al, , 2022Italia et al, 2017;Kelemen et al, 2022;Lang et al, 2012;Wang et al, 2014;Zheng et al, 2018a).…”
Section: Introductionmentioning
confidence: 99%
“…Parallel efforts from our lab have led to the discovery of a broad range of E. coli tyrosyl-tRNA synthetase (EcTyrRS) and E. coli Leucyl-tRNA synthetase (EcLeuRS) variants with a variety of ncAA incorporation properties, including new-to-yeast ncAA incorporation and improved selectivity and activity for known ncAAs . In addition, work by Chatterjee and coworkers in engineered E. coli strains has led to the identification of additional EcaaRS variants derived from EcTyRS and EcTrpRS with unique substrate preferences for use in mammalian cells (Grasso et al, 2022;Osgood et al, 2022).…”
Section: Introductionmentioning
confidence: 99%